INTRODUCTION
============

In the past decade a novel mode of activity control of regulatory proteins has been revealed in bacteria. In this mode, transcription factors shuttle between their binding sites on the chromosome and the inner face of the cytoplasmic membrane, where they are held inactive. In response to a specific stimulus, these regulators are again released from the membrane and can bind back to their target sites on the chromosome \[for a recent review see ([@b1])\].

The first example of such a mechanism was the regulation of the proline utilization (*put*) operon by PutA in *Salmonella typhimurium* ([@b2]). PutA has been shown to be a bi-functional protein. In the absence of proline, PutA remains in the cytoplasm, where it binds to the *put* operators and represses *put* gene expression. When an excess of proline is present, proline binds to PutA. Binding of proline, combined with reduction of the PutA protein by the membrane-associated electron transport chain, leads to release of PutA from its operators and its association with the membrane. From this location it catalyzes the degradation of proline to glutamate.

Another elegant system where membrane sequestration of a repressor leads to induction of its assigned genes is represented by the *mlc* regulon in *Escherichia coli*. The repressor Mlc controls expression of several genes involved in carbohydrate utilization \[for reviews see ([@b1],[@b3])\]. One of them is *ptsG* encoding the EII^Glc^ transport protein of the phosphotransferase system (PTS). Mlc is in turn regulated by the transport activity of EII^Glc^. In the absence of substrate for EII^Glc^, Mlc binds to its operator sites and represses transcription. When EII^Glc^ is engaged in transport, it binds Mlc, thereby sequestering it to the membrane, which leads to concomitant de-repression of the Mlc-controlled genes. It has recently been shown that an artificial attachment of Mlc to the cytoplasmic membrane by fusion to the LacY permease causes de-repression of Mlc-controlled genes even in the absence of EII^Glc^, suggesting that tethering of Mlc to the membrane alone, rather than binding to EII^Glc^, may lead to its inactivation as a repressor ([@b4]). Not only repressors but also activator proteins were shown to be sequestered to the membrane in response to their cognate signals and concomitantly kept inactive. These include MalT of *E.coli* ([@b1],[@b5]), TraR of *Agrobacterium tumefaciens* ([@b6]) and NifL of *Klebsiella pneumoniae*, in this case an inhibitor of a gene activator protein ([@b7]). In most of these cases the molecular reason for inactivity of the membrane-localized regulatory proteins is not clear, but it has been proposed that a spatial gap may exist between the membrane and the chromosome with the consequence that the transcription factors have to 'shuttle' back to the nucleoid to gain access to their binding sites in the chromosome ([@b1],[@b7]). However, in one case, the DNA binding gene activator protein ToxR of *Vibrio cholerae*, it has been demonstrated that this protein is naturally membrane-bound ([@b8]). In addition, we have previously shown that the transcriptional antiterminator protein BglG from *E.coli* that is regulated in its activity by a membrane spanning sugar transport protein can be artificially tethered to the membrane without impairing its function. The membrane-bound BglG protein is capable of interacting with its chromosomally encoded nascent RNA target sequence, catalyzing transcriptional read-through with virtually no difference to wild-type BglG, and it is perfectly regulated in its activity ([@b9]). These observations suggested that in principle there should be no mechanistic necessity for a regulatory protein like BglG to leave the place of its own regulation, i.e. the membrane, in order to interact with its target sequences.

However, for activator proteins like ToxR or BglG transient interactions with their cognate target sequences could be sufficient to stimulate gene expression. Furthermore, actively transcribed DNA is believed to often reside close to the membrane, especially when co-translational insertion of proteins into the membrane takes place. For efficient transcriptional repression, however, occupation of the operator binding site by the repressor protein for most of the time is required and no or little transcription should occur that could redirect the operator DNA to the membrane. It, therefore, was an open question whether repressor proteins could exist or be engineered that function from the cytoplasmic membrane. Here, we addressed this question and artificially anchored the *E.coli* Lac repressor to the cytoplasmic membrane. We demonstrate that this membrane-attached LacI protein perfectly represses transcription initiation at a chromosomally located *tac* operator--promoter and that it can be released from repression by the addition of isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside (IPTG) as inducer. Our experiments suggest that membrane-attached and soluble Lac repressor proteins find their operator site in the chromosome with similar efficiency. Together, our results suggest that membrane sequestration of a repressor protein *per se* cannot be the reason for its inactivation. Other mechanisms are required. The concept that membrane sequestration provides a spatial separation from and prevents access to the chromosome has thus to be revised.

MATERIALS AND METHODS
=====================

Plasmids, strains and growth conditions
---------------------------------------

The strains and plasmids used and their relevant characteristics are listed in [Table 1](#tbl1){ref-type="table"}. For DNA cloning, standard procedures were followed ([@b10]). The correct nucleotide sequences of PCR-derived fragments in the various plasmids were verified by DNA sequencing. Bacteria were routinely grown in 2YT broth supplemented with the appropriate antibiotics (kanamycin at 30 μg/ml, chloramphenicol at 10 μg/ml and ampicillin at 100 μg/ml, if not otherwise indicated).

Construction of chimeric *lacI* fusion genes
--------------------------------------------

Plasmid pFDX4151 was the ancestor of plasmids carrying the different chimeric *lacI* derivatives. It was constructed by a three fragment ligation combining the ClaI--PstI- and the Psp1406I--ClaI-fragments of plasmid pFDX500 ([@b11]) with a PCR fragment which was amplified with primers \#631 (5′-CGTATAACGTTACTGGTTTCATATGCACCACCCTGAATTG) and \#632 (5′-GCCGGGAAGCTAGAG) from plasmid pFDX500 as template and digested with Psp1406I and PstI. This construction changed the start codon of *lacI* from GTG to ATG and simultaneously created an NdeI site overlapping with the start codon that allowed the insertion of foreign DNAs in-frame with *lacI*. For construction of the *M13gene8*-*lacI* fusion gene, the *M13gene8* was amplified by using primers \#293 (5′-GGGATTTAAACATATGAAAAAGTCTTTAGTCCTCAAAGC) and \#294 (5′-TTTAAAGTACTTGCTTTCGAGGTGAATTTCTTAAA) and plasmid M13mp18 as template. The PCR fragment was digested at the NdeI and Csp6I sites within the primers and inserted into the NdeI site of plasmid pFDX4151, resulting in plasmid pFDX4152. For the construction of plasmid pFDX4154 carrying the *galK′-lacI* fusion gene, the 5′-part of *galK* encompassing the first 32 codons was amplified by using the primers \#636 (5′-GATATACATATGGCTAG) and \#637 (5′-CACTGCATTAATAGCAAGGACAGGC) and plasmid pFDX3225 ([@b12]) as template. The PCR fragment was digested at the NdeI and AseI sites within the primers and inserted into the NdeI site of plasmid pFDX4151. Plasmids pFDX4155 and pFDX4156 carrying the *galK′*-λ*cI′*-*lacI* and the *gene8*-λ*cI′*-*lacI* fusion genes, respectively, were constructed in two steps. First, codons 96--132 of the λ*cI* gene encoding a flexible linker were amplified by using primers \#634 (5′-AAAGAGTATCATATGGACCCGTCACTT) and \#635 (5′-CTCCTCATTAATGCTTACCCATCTCTC) and plasmid λdv1 ([@b13]) as template. The PCR fragment was digested at the NdeI and MseI sites within the primers and inserted into the NdeI site of plasmid pFDX4151 resulting in the intermediate construct pFDX4153 carrying a λ*cI′*-*lacI* fusion gene. Next, the digested PCR fragments from above, encompassing the 5′-part of *galK* and *gene8*, respectively, were inserted into the NdeI site of plasmid pFDX4153, resulting in plasmids pFDX4155 and pFDX4156. In order to replace the ribosomal binding site (RBS) in front of *lacI* and its various chimeric derivatives, the sequence upstream was amplified by using primers \#646 (5′-GTTGCCATTGCTGCAGGC) and \#647 (5′-GCATATCGCATATGTATATCTCCTTCTTGACTCTCTTCCGGGCGCTAT; contains the RBS of *T7gene10*) and plasmid pFDX4152 as template. The PCR fragment was digested at the PstI and NdeI sites within the primers and used to replace the corresponding fragment in plasmids pFDX4151, pFDX4152, pFDX4154, pFDX4155 and pFDX4156 resulting in plasmids pFDX4165, pFDX4157, pFDX4158, pFDX4159 and pFDX4160, respectively.

Construction of a *tacOP-lacZ* reporter cassette and integration into the chromosomal *attB* site
-------------------------------------------------------------------------------------------------

Plasmid pFDX3551 carries a *tacOP-lacZ* cassette with the relatively weak RBS sequence of the *bglG* gene in front of *lacZ*. It was constructed by replacement of the HindIII--ClaI fragment of plasmid pFDX3157 ([@b12]) encompassing gene *bglG* by the HindIII--ClaI fragment of plasmid pFDX3549 ([@b12]) encompassing the *lacZ* gene. Plasmid pFDX3552 is isogenic with plasmid pFDX3551 but carries the strong RBS sequence of *gene10* of phage *T7* in front of *lacI*. Its construction involved several steps, and details are available on request. Integration of the *tacOP-lacZ* cassette of plasmid pFDX3552 by site-specific recombination into the bacteriophage λ attachment site *attB*, was achieved with the integration system provided by Diederich *et al*. ([@b14]) as described previously ([@b12]).

Determination of β-galactosidase activities
-------------------------------------------

Enzyme assays were performed according to the method of Miller ([@b15]) as described previously ([@b16]). The bacteria were grown in M9 minimal medium supplemented with 1% (w/v) glycerol, 20 μg/ml proline, 1 μg/ml thiamine, 0.66% (w/v) casamino acids and the appropriate antibiotics. If not otherwise indicated, overnight cultures were inoculated to an OD~600~ of 0.15 and grown for 1 h at 37°C. Then, 1 mM IPTG was added where necessary and growth was continued for 2 h before the cultures were harvested. Samples were assayed in triplicate and each experiment was repeated three times using independent transformants. Enzyme activities are expressed in Miller units.

*In vivo* pulse-chase \[^35^S\]methionine labeling of proteins
--------------------------------------------------------------

The pulse-chase labeling of proteins with \[^35^S\]methionine was carried out as described previously ([@b9]).

Subcellular fractionation of \[^35^S\]methionine-labeled proteins
-----------------------------------------------------------------

Separation of \[^35^S\]methionine-labeled soluble and membrane proteins was performed by sucrose gradient centrifugation as described previously ([@b9]).

RESULTS
=======

Construction, stability and subcellular localization of chimeric Lac repressor proteins
---------------------------------------------------------------------------------------

It has previously been shown that the 50 amino acid residue major coat protein of bacteriophage *M13* encoded by *M13gene8* is a suitable tool to stably anchor a protein to the cytoplasmic membrane. For this purpose the protein to be anchored is fused to the *C*-terminus of the coat protein ([@b9],[@b17]). We made use of this tool to attach the Lac repressor to the membrane. To this end, a translational fusion of the *lacI* gene encoding Lac repressor to the exact 3′ end of *gene8* was constructed and placed on a low copy plasmid under control of the *lacI* promoter. In order to determine whether an *N*-terminal extension would generally impair the function of Lac repressor, a control fusion comprising the first 32 codons of the *galK* gene fused to *lacI* was also constructed. The *galK* gene encodes galactokinase, a soluble protein ([@b9]).

The DNA binding domain of Lac repressor encompasses the first 60 *N*-terminal amino acid residues. It thus appeared conceivable that the tight tethering of this domain to the membrane could negatively interfere with its DNA binding ability. We, therefore, constructed additional fusion genes in which codons 96--132 of the λ*cI* repressor gene encoding a flexible linker ([@b18]) were placed between the *lacI*- and the *gene8*- or *galK*-part of the respective fusion genes.

In order to allow investigation by gel electrophoresis of whether the fusion proteins are stable *in vivo* and indeed attached to the membrane, a second set of isogenic vectors was constructed in which the RBS of *lacI* was replaced by the stronger RBS of gene*10* of phage*T7*, leading to a higher expression of the different Lac repressor derivatives. Transformants carrying the respective expression plasmids were analyzed by \[^35^S\]methionine labeling and subsequent SDS--PAGE ([Figure 1](#fig1){ref-type="fig"}). As a control, the untransformed strain was also employed. Labeled protein bands became visible, which were exclusively present in the extracts of the respective transformants expressing LacI (39.6 kDa), the φ(Gene8--λCI--LacI) fusion (49.6 kDa) or the φ(Gene8--LacI) fusion (45.3 kDa). The positions of these proteins on the gel fitted well with the calculated molecular weight of the respective LacI derivatives, indicating that they are properly expressed ([Figure 1](#fig1){ref-type="fig"}, compare lanes 1, 7, 13 and 19; data not shown for the GalK--LacI and the GalK--λCI′--LacI fusion proteins).

In order to test the stability of the different LacI derivatives, the labeled cultures were chased with unlabeled methionine for different times prior to protein extraction and SDS--PAGE. All LacI derivatives were stable over the tested period of 30 min, as was the wild-type LacI protein ([Figure 1](#fig1){ref-type="fig"}, compare lanes 14--18 and 20--24 with lanes 8--12; data not shown for the GalK--LacI and the GalK--λCI′--LacI fusion proteins).

Next, we wanted to verify that the Gene8 fusion proteins were indeed tightly attached to the cytoplasmic membrane. We, therefore, performed a subcellular fractionation of \[^35^S\]methionine-labeled transformants harboring the wild-type *lacI* gene or the φ(*gene8*-*lacI*) and the φ(*gene8*-λ*cI*′*-lacI*) fusion genes, respectively, by sucrose gradient centrifugation, as described previously ([@b9]). The untransformed strain served as a control. The soluble and membrane fractions were analyzed by SDS--PAGE along with the unfractionated samples ([Figure 2](#fig2){ref-type="fig"}). It can be seen that both the φ(Gene8-LacI) as well as the φ(Gene8--λCI′--LacI) fusion proteins were present in the membrane fraction ([Figure 2](#fig2){ref-type="fig"}, lanes 8 and 11) but not in appreciable amounts in the soluble fraction ([Figure 2](#fig2){ref-type="fig"}, lanes 7 and 10). The wild-type LacI protein, on the other hand, was only visible in the soluble fraction, as expected ([Figure 2](#fig2){ref-type="fig"}, lane 4). Its amount was, however, lower than that detected with the \[^35^S\]methionine-labeled whole cell extracts analyzed in [Figure 1](#fig1){ref-type="fig"}. Since the amount of LacI was similarly reduced in case of the unfractionated control sample ([Figure 2](#fig2){ref-type="fig"}, lane 6), it is feasible that this reduction was due to the TCA precipitation step which was performed with all samples analyzed in [Figure 2](#fig2){ref-type="fig"} but not with those presented in [Figure 1](#fig1){ref-type="fig"}. This difference has, however, no impact on the main conclusion that both, the φ(Gene8--LacI) as well as the φ(Gene8--λCI′--LacI) fusion protein are stable and are anchored to the cytoplasmic membrane.

Membrane-attached Lac repressor is active in transcriptional repression
-----------------------------------------------------------------------

The important question was whether or not the membrane-attached LacI proteins are functional in repression and thus in operator binding, and if so, whether or not repression by these proteins could be relieved by the addition of IPTG, a gratuitous inducer for wild-type Lac repressor. To this end, strain R1279 in which the chromosomal *lac* operon is deleted, was co-transformed with the various plasmids carrying the different *lacI* derivatives under control of the wild-type *lacI* RBS and in addition with reporter plasmid pFDX3551. This plasmid carries a *lacZ* reporter gene under control of the *tac* promoter which is controlled by the main *lac* operator *O*~1~ that overlaps with its transcriptional start site. When strain R1279 was transformed with this reporter plasmid alone, high β-galactosidase activities of ∼5000 U were produced which were unaffected by the absence or presence of IPTG, as expected ([Figure 3](#fig3){ref-type="fig"}, bars 1). The additional presence of plasmid pFDX500 delivering wild-type Lac repressor led to the synthesis of 51 U in the absence and of 1640 U in the presence of IPTG. Thus, the expression of *lacZ* was repressed 32-fold by wild-type Lac repressor in this reporter system ([Figure 3](#fig3){ref-type="fig"}, bars 2). Nearly identical values were obtained when the LacI delivering plasmid pFDX4151 carrying an NdeI site that overlaps with the *lacI* start codon was present ([Figure 3](#fig3){ref-type="fig"}, bars 3). Thus, the introduction of this site and the exchange of the GTG start codon against ATG had no appreciable effect on repression. The expression of the φ(GalK--LacI) fusion protein yielded activities which were similar to those obtained with the wild-type LacI protein ([Figure 3](#fig3){ref-type="fig"}, compare bars 3 and 4), indicating that the fusion of a foreign polypeptide to the N-terminus of LacI may in general not have deleterious effects on repression and thus on binding of the Lac repressor to its operator. Expression of the membrane-anchored φ(Gene8--LacI) fusion protein led to the synthesis of 2250 U of β-galactosidase activities in the presence of IPTG which were reduced to 120 U in its absence. Thus, the membrane-anchored φ(Gene8--LacI) protein was indeed able to efficiently repress expression of the *lacZ* reporter gene. Moreover, this repression could be relieved 19-fold by the addition of IPTG ([Figure 3](#fig3){ref-type="fig"}, bars 5). The presence of the flexible protein linker of the λCI protein had no effect on the repression activity of the φ(GalK--λCI′--LacI) protein when compared with the φ(GalK--LacI) protein without this linker ([Figure 3](#fig3){ref-type="fig"}, compare bars 4 and 6). In contrast, the φ(Gene8--λCI′--LacI) protein was less active in transcriptional repression when compared with the φ(Gene8--LacI) fusion protein lacking the λCI-linker. Therefore, induction was only 10-fold ([Figure 3](#fig3){ref-type="fig"}, compare bars 7 and 5). Obviously, the λCI-linker negatively interfered with the operator binding ability of this membrane-attached Lac repressor protein.

The membrane-attached LacI proteins regulate expression of a chromosomal gene
-----------------------------------------------------------------------------

The experiments presented above ([Figure 3](#fig3){ref-type="fig"}) demonstrate that the membrane-attached Lac repressor proteins are indeed active in transcriptional repression. However, in these tests the *lacO~1~* target site was encoded on a plasmid. Although plasmids appear to be clustered and partitioned within a cell ([@b19]) they may be more readily accessible by membrane-localized DNA binding proteins than sequences within the nucleoid. The question was thus still open whether the membrane-located Lac repressor protein would have free access and tightly bind to a chromosomally located operator site. In order to address this question, the *tacOP-lacZ* reporter cassette present in plasmid pFDX3551 was integrated into the λ *attB* site in the chromosome by site-specific recombination. However, this strain yielded very low β-galactosidase activities \[\<100 Miller units already in the absence of Lac repressor (data not shown)\], making it difficult to precisely compare activities of the various Lac repressor derivatives. Therefore, the isogenic strain R2171 was constructed in which the more efficient ribosome binding site of gene*10* of phage *T7* was placed in front of *lacZ*. This strain yielded ∼4000 U of β-galactosidase, a convenient activity for the intended experiments. As expected, the presence of IPTG had no effect on this activity ([Figure 4](#fig4){ref-type="fig"}, bars 1). Transformants of this strain harboring plasmids pFDX500 and pFDX4151, respectively, that both encode the wild-type Lac repressor yielded 30--40 U of β-galactosidase. These activities increased 70--80-fold in the presence of IPTG ([Figure 4](#fig4){ref-type="fig"}, bars 2 and 3), verifying that expression of the chromosomal *lacZ* reporter cassette is perfectly regulated by the wild-type repressor in an inducer-dependent manner. Very similar results were obtained in the presence of plasmids pFDX4154 and pFDX4155 encoding the φ(GalK--LacI) and the φ(GalK--λCI′--LacI) fusion proteins, respectively, demonstrating once again that this fusion of a foreign peptide to the N-terminus of LacI has no negative effect on Lac repressor function ([Figure 4](#fig4){ref-type="fig"}, bars 4 and 6). When strain R2171 was transformed with plasmid pFDX4152 that encodes the membrane-anchored φ(Gene8-LacI) chimeric repressor, the transformants synthesized only 34 U of β-galactosidase. Thus, the membrane-anchored repressor is able to repress the *tac* promoter present in the chromosome as efficiently as the wild-type repressor. Addition of IPTG resulted in 3760 U or a 111-fold induction ([Figure 4](#fig4){ref-type="fig"}, bars 5). Thus, the membrane-attached LacI derivative is capable of regulating the expression of the chromosomal *lacZ* reporter gene as efficiently as the wild-type repressor. Finally, the membrane-anchored φ(Gene8--λCI--LacI) fusion protein delivered by plasmid pFDX4156 was tested. Presence of this plasmid led to 53 U of β-galactosidase in the absence of IPTG and to 3560 U in its presence, which is a 67-fold induction ([Figure 4](#fig4){ref-type="fig"}, bars 7). This result corroborates the above observation ([Figure 3](#fig3){ref-type="fig"}, bars 7) that the presence of the λCI-linker may slightly impair operator binding of the membrane-anchored repressor.

Membrane-attached and soluble LacI proteins exhibit similar kinetics of binding to chromosomally located operator *lacO1*
-------------------------------------------------------------------------------------------------------------------------

The experiments above demonstrated that the membrane-attached φ(Gene8--LacI) fusion protein is capable of efficiently repressing expression of the *lacZ* reporter gene and thus of binding to a chromosomally located operator, *lacO1*. The addition of IPTG led to release from this repression. Moreover, repression as well as inducibility were quite similar with its membrane-anchored fusion derivatives as compared with the wild-type repressor, suggesting that even the equilibrium constants for binding of the operator sequence are similar. However, in the experiments described above, cultures were pregrown without IPTG, split and subsequently grown in the presence or absence of IPTG before enzyme activities were determined. Thus, these data allow no conclusion about the initial rate of operator occupancy. To address this question, cultures of the transformants shown in [Figure 4](#fig4){ref-type="fig"} were pregrown in the presence of IPTG. Subsequently, they were washed free of IPTG to allow establishment of repression, and the kinetics of decline of β-galactosidase as a function of time was analyzed ([Figure 5](#fig5){ref-type="fig"}). In the absence of repressor, specific activity remained constant as expected ([Figure 5](#fig5){ref-type="fig"}, diamonds). In all other cases, enzyme activities declined with time as a result of re-establishment of repression. In these cases, the remaining activities represent the sum of dilution of enzyme activities by cell growth and of the basal enzyme synthesis under repressing conditions. As can be seen, the slopes of decline of enzyme activities are similar in all cases. The differences that can be seen reflect the differences in repression as revealed by the data in [Figure 4](#fig4){ref-type="fig"} and support the conclusion that the membrane-anchored φ(Gene8--LacI) repressor protein represses the *tac* promoter at least as efficient as the wild-type repressor. Thus, not only the equilibrium constants but also the initial rate of finding the operator target appears to be similar within the time frame of these kinetics for the membrane-localized and soluble repressor proteins. Taken together, it can be concluded that a membrane-attached Lac repressor protein can find and bind its operator sequence present in the chromosome as efficient as the soluble wild-type LacI protein.

DISCUSSION
==========

In this study, we have demonstrated that the *E.coli* Lac repressor retains its activity when it is artificially fixed with its N-terminus to the inner face of the cytoplasmic membrane. From this location it represses the expression of a *tacOP-lacZ* reporter cassette present on a plasmid and even in the chromosome with the same efficiency as the wild-type repressor. Moreover, addition of IPTG as an inducer resulted in the same de-repression exhibited by the wild-type repressor ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). The data indicate that the equilibrium constants for the occupation of chromosomal *lac* operator *O~1~* must be similar for the membrane-localized φ(Gene8--LacI) protein and the wild-type Lac repressor ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Pulse-chase experiments verified that the chimeric φ(Gene8--LacI) protein is stable ([Figure 1](#fig1){ref-type="fig"}). Subcellular fractionations demonstrated that the chimeric repressor protein is stably anchored to the membrane ([Figure 2](#fig2){ref-type="fig"}).

However, we did not demonstrate that the membrane-anchored fusion protein is capable of regulating the authentic *lac* operon. Indeed, when we replaced the wild-type *lacI* gene by the *gene8-lacI* fusion gene within the context of the authentic *lac* operon in the chromosome, expression of the operon was only weakly repressed. However, very similar results were obtained when the *lacI* gene was replaced by one of the *galK-lacI* fusion genes (data not shown). Thus, a fusion to the N-terminus of the Lac repressor encompassing its DNA binding domain generally leads to a defect in repressor function in its authentic context, the *lac* operon. In this context, full repression requires cooperative binding of LacI to one of two auxiliary operators in addition to operator *O*~1~ ([@b20]). This cooperative binding requires the tetramerization of LacI ([@b21]). It may be concluded from our data that a fusion of a foreign peptide to the *N*-terminus of LacI in general may negatively interfere with its binding capability to the main operator, *O*~1~, when auxiliary binding sites are present.

Nevertheless, our data clearly demonstrate that a membrane-anchored Lac repressor does have unrestricted access to the chromosomally located *lacO1* operator. Thus, not only transcriptional antiterminator proteins like the *E.coli* BglG protein can be engineered to work from the membrane ([@b9]) but also transcriptional repressor proteins that have to occupy their binding sites for most of the time and be able to bind back fast in order to achieve efficient repression. Thus, a physical gap between membrane and chromosome does not exist. It appears that either the chromosome already resides in the vicinity of the membrane, making a physical movement of the regulator unnecessary, or that the chromosome dynamically rearranges very fast allowing free access to its sequences from the membrane. This view is in agreement with early studies that reported the chromosome to be associated with the cytoplasmic membrane ([@b22],[@b23]).

A major consequence of our results is that membrane sequestration of gene regulators in terms of their physical separation from the chromosome alone cannot account for their inactivation. A well-studied case of a gene activator that shuttles between the chromosome and the membrane is MalT of *E.coli*. Upon maltose transport MalT is released from the membrane-bound subunit MalK of the maltose transporter which is a prerequisite for MalT activity. It has been known for a long time that even a soluble form of MalK inhibits *mal* gene expression *in vivo*, at least when overproduced ([@b24]). Recently, it has been demonstrated that soluble MalK is able to inhibit MalT activity in a purified transcription system by blocking the binding of the inducer maltotriose to MalT ([@b25]). Thus, membrane sequestration of MalT appears to be just a secondary effect as a consequence of its interaction with the membrane-localized MalK subunit rather than to be directly responsible for MalT inactivity. The quorum-sensing activator protein TraR of *A.tumefaciens* in the presence of the homoserine lactone signal exists as an active dimer in the cytoplasm, whereas in its absence TraR is sequestered to the membrane in an inactive, monomeric form ([@b6]). It, thus, appears that the subcellular localization of TraR modulates its oligomerization state and thereby indirectly regulates the activity of TraR.

In a recent study, it was found that different sites in the chromosome significantly differ in their accessibility to phage λ integrase catalyzed site-specific recombination. In fact, several loci were found that were even designated 'black holes' ([@b26]). On the other hand, the *E.coli* chromosome is generally accessible *in vivo* along its entire length to restriction enzymes suggesting that there are no extensive stably bound structural components that prevent their access ([@b27]). Our tests were performed with lac operator *O*~1~ integrated into the λ *attB* site of the *E.coli* chromosome. We are currently investigating with the aid of a transposon borne *tacOP-lacZ* cassette whether differences in the accessibility to repression by the membrane-bound Lac repressor exist within the chromosome. Our finding that membrane-bound Lac repressor can tightly bind to its operator should in principal allow to tether almost any DNA sequences containing *lac* operator to the cytoplasmic membrane and to study the consequences. For example, DNA topology or chromatin structure could be captured between two operator sites and released upon the addition of IPTG, and the consequences for recombination, gene expression or DNA replication could be studied.
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![Synthesis and stability of LacI derivatives. Strain R1279 was transformed with plasmid pFDX4160 carrying the φ(*gene8*-λ*cI*′*-lacI*) fusion gene (lanes 13--18) or with plasmid pFDX4157 carrying the φ(*gene8*-*lacI*) fusion gene (lanes 19--24) under control of the wild-type *lacI* promoter, respectively. For comparison, a transformant with the isogenic plasmid pFDX4165 carrying wild-type *lacI* (lanes 7--12) as well as the untransformed strain (lanes 1--6) were also employed. Aliquots of the cultures were pulse-labeled with \[^35^S\]methionine and subsequently chased with unlabeled methionine for the times indicated in the figure. Proteins were separated by SDS--PAGE and analyzed by autoradiography and phospho-imager analysis. The positions of molecular weight standards are given on the left (in kDa).](gki549f1){#fig1}

![Subcellular fractionation demonstrating that both, the φ(Gene8--LacI) as well as the φ(Gene8--λCI′--LacI) fusion proteins, are membrane-anchored. The untransformed strain R1279 as well as its various transformants ([Figure 1](#fig1){ref-type="fig"}) were labeled with \[^35^S\]methionine. Subsequently the cells were gently lysed, and half of the lysates were subjected to sucrose gradient centrifugation to separate soluble (S) and membrane (M) proteins. The remaining halves were kept on ice during the fractionation procedure and served as samples representing total protein (T). The samples were separated by SDS--PAGE, followed by autoradiography and phospho-imager analysis. Lanes 1--3, strain R1279 (untransformed); lanes 4--6, R1279/pFDX4165 (wild-type *lacI*); lanes 7--9, R1279/pFDX4157 \[φ(*gene8-lacI*)\]; lanes 10--12, R1279/pFDX4160 \[φ(*gene8*-λ*cI*′*-lacI*)\]. The positions of molecular weight standards are given on the left (in kDa), and the positions of the respective LacI derivatives are indicated by arrows on the right.](gki549f2){#fig2}

![The membrane-anchored LacI fusion proteins regulate expression of a plasmid encoded *tacOP-lacZ* reporter cassette in an inducer-dependent manner. Strain R1279 was transformed with reporter plasmid pFDX3551 which carries the *tacOP-lacZ* cassette and in addition with one of various plasmids delivering LacI or its fusion derivatives. β-Galactosidase activities of these transformants were determined in the absence or presence for 2 h of IPTG, as indicated. Bars 1: R1279/pFDX3551 (single transformant); bars 2: R1279/pFDX3551/pFDX500 (wild-type *lacI*); bars 3: R1279/pFDX3551/pFDX4151 (wild-type *lacI* with ATG-start codon and NdeI site); bars 4: R1279/pFDX3551/pFDX4154 \[φ(*galK-lacI*)\]; bars 5: R1279/pFDX3551/pFDX4152 \[φ(*gene8-lacI*)\]; bars 6: R1279/pFDX3551/pFDX4155 \[φ(*galK*-λ*cI*′*-lacI*)\]; and bars 7: R1279/pFDX3551/pFDX4156 \[φ(*gene8*-λ*cI*′*-lacI*)\]. The reason for the high enzyme activities seen in the absence of a Lac repressor delivering plasmid (bars 1) as compared with those obtained in its presence when IPTG as inducer was additionally present is unclear. Similar high activities were seen when the vector plasmid without a *lacI* gene was present (data not shown). One reason could be that induction by IPTG is incomplete.](gki549f3){#fig3}

![Repression and de-repression of a chromosomal *tacOP-lacZ* reporter cassette by the membrane-anchored LacI fusion proteins. Strain R2171 carrying a *tacOP-lacZ* reporter cassette integrated into the λ*attB* site in the chromosome was transformed with the various plasmids carrying wild-type *lacI* and its derivatives, respectively. Subsequently, β-galactosidase activities were determined as in [Figure 3](#fig3){ref-type="fig"}. Bars 1: R2171 (untransformed strain); bars 2: R2171/pFDX500 (wild-type *lacI*); bars 3: R2171/pFDX4151 (wild-type *lacI* with ATG-start codon and NdeI site); bars 4: R2171/pFDX4154 \[φ(*galK-lacI*)\]; bars 5: R2171/pFDX4152 \[φ(*gene8-lacI*)\]; bars 6: R2171/pFDX4155 \[φ(*galK*-λ*cI*′*-lacI*)\]; and bars 7: R2171/pFDX4156 \[φ(*gene8*-λ*cI*′*-lacI*)\].](gki549f4){#fig4}

![Kinetics of establishment of repression by the membrane-anchored LacI fusion proteins at the chromosomal *tacOP-lacZ* cassette. Strain R2171 and its various transformants ([Figure 4](#fig4){ref-type="fig"}) were pregrown in the presence of 1 mM IPTG. Subsequently, the cells were washed free of IPTG and growth was continued in IPTG-free medium. Samples were taken after the removal of IPTG at the times indicated and β-galactosidase activities were determined.](gki549f5){#fig5}

###### 

Strains and plasmids used in this study

                 Genotype or relevant structures                                                                                                                   Source or reference
  -------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------
  Strains                                                                                                                                                          
      R1279      CSH50 Δ(*pho-bgl*)201 Δ(*lac-pro*) *ara thi*                                                                                                      ([@b16])
      R2171      As R1279 but *attB*::\[*tacOP*-*lacZ*, *bla*\]; *RBS* of phage *T7gene10* in front of *lacZ*                                                      pFDX3552→R1279
  Plasmids                                                                                                                                                         
      M13mp18    M13 phage cloning vector                                                                                                                          ([@b28])
      pFDX500    *lacI*, *neo*, *ori* p15A                                                                                                                         ([@b11])
      pFDX3225   φ(*galK*′*-bglG*) under control of *Ptac*, *tet*, *ori* p15A                                                                                      ([@b12])
      pFDX3401   λ *int* under control of λP~R~, λ*cI~857~* (*cat*; *ori* pSC101-*rep^TS^*)                                                                        ([@b12])
      pFDX3551   pLDR10 derivative for the insertion of a *tacOP*-*lacZ* cassette into the *attB* site; RBS of gene *bglG* in front of *lacZ*, *bla*, *ori* pMB1   This study
      pFDX3552   As pFDX3551, but RBS of phage *T7gene10* in front of *lacZ*                                                                                       This study
      pFDX4151   As pFDX500, but with a NdeI site overlapping with the *lacI* ATG start codon                                                                      This study
      pFDX4152   As pFDX4151, but *lacI* fused to *M13gene8*                                                                                                       This study
      pFDX4153   As pFDX4151, but *lacI* fused to λ*cI*′ (codons 96--132)                                                                                          This study
      pFDX4154   As pFDX4151, but *lacI* fused to *galK*′ (codons 1--32)                                                                                           This study
      pFDX4155   As pFDX4151, but *lacI* fused to *galK*′-λ*cI*′                                                                                                   This study
      pFDX4156   As pFDX4151, but *lacI* fused to *M13gene8*-λ*cI*′                                                                                                This study
      pFDX4157   As pFDX4152, but *RBS* of phage *T7gene10* in front of φ(*M13gene8*-*lacI*)                                                                       This study
      pFDX4158   As pFDX4154, but *RBS* of phage *T7gene10* in front of φ(*galK*′-*lacI*)                                                                          This study
      pFDX4159   As pFDX4155, but *RBS* of phage *T7gene10* in front of φ(*galK*′-λ*cI*′*-lacI*)                                                                   This study
      pFDX4160   As pFDX4156, but *RBS* of phage *T7gene10* in front of φ(*M13gene8*-λ*cI*′-*lacI*)                                                                This study
      pFDX4165   As pFDX4151, but *RBS* of phage *T7gene10* in front of *lacI*                                                                                     This study
      pLDR10     Multiple cloning site, λ*attP*, *bla*, *cat*, *ori* pMB1                                                                                          ([@b14])
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